de la Lastra CA[Author] - Search Results

Year	Number of Results
1995	1
1996	1
1997	1
2000	1
2001	1
2002	1
2004	3
2005	1
2006	1
2007	3
2008	1
2009	1
2010	5
2011	4
2012	5
2013	4
2014	1
2015	1
2021	0

1

Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications.

de la Lastra CA, Villegas I. de la Lastra CA, et al. Biochem Soc Trans. 2007 Nov;35(Pt 5):1156-60. doi: 10.1042/BST0351156. Biochem Soc Trans. 2007. PMID: 17956300 Review.

2

Polyphenols and human health: a prospectus.

Visioli F, De La Lastra CA, Andres-Lacueva C, Aviram M, Calhau C, Cassano A, D'Archivio M, Faria A, Favé G, Fogliano V, Llorach R, Vitaglione P, Zoratti M, Edeas M. Visioli F, et al. Among authors: de la lastra ca. Crit Rev Food Sci Nutr. 2011 Jul;51(6):524-46. doi: 10.1080/10408391003698677. Crit Rev Food Sci Nutr. 2011. PMID: 21929330 Review.

3

Sirtuin modulators: mechanisms and potential clinical implications.

Sanchez-Fidalgo S, Villegas I, Sanchez-Hidalgo M, de la Lastra CA. Sanchez-Fidalgo S, et al. Among authors: de la lastra ca. Curr Med Chem. 2012;19(15):2414-41. doi: 10.2174/092986712800269272. Curr Med Chem. 2012. PMID: 22455589 Review.

4

Melatonin, a natural programmed cell death inducer in cancer.

Sánchez-Hidalgo M, Guerrero JM, Villegas I, Packham G, de la Lastra CA. Sánchez-Hidalgo M, et al. Among authors: de la lastra ca. Curr Med Chem. 2012;19(22):3805-21. doi: 10.2174/092986712801661013. Curr Med Chem. 2012. PMID: 22612707 Review.

5

Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications.

de la Lastra CA, Villegas I, Sánchez-Fidalgo S. de la Lastra CA, et al. Curr Pharm Des. 2007;13(9):933-62. doi: 10.2174/138161207780414241. Curr Pharm Des. 2007. PMID: 17430191 Review.

6

Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications.

de la Lastra CA, Villegas I. de la Lastra CA, et al. Mol Nutr Food Res. 2005 May;49(5):405-30. doi: 10.1002/mnfr.200500022. Mol Nutr Food Res. 2005. PMID: 15832402 Review.

7

Anti-inflammatory intestinal activity of Arctium lappa L. (Asteraceae) in TNBS colitis model.

de Almeida AB, Sánchez-Hidalgo M, Martín AR, Luiz-Ferreira A, Trigo JR, Vilegas W, dos Santos LC, Souza-Brito AR, de la Lastra CA. de Almeida AB, et al. Among authors: de la lastra ca. J Ethnopharmacol. 2013 Mar 7;146(1):300-10. doi: 10.1016/j.jep.2012.12.048. Epub 2013 Jan 10. J Ethnopharmacol. 2013. PMID: 23313393 Free article.

8

Dietary squalene supplementation improves DSS-induced acute colitis by downregulating p38 MAPK and NFkB signaling pathways.

Sánchez-Fidalgo S, Villegas I, Rosillo MÁ, Aparicio-Soto M, de la Lastra CA. Sánchez-Fidalgo S, et al. Among authors: de la lastra ca. Mol Nutr Food Res. 2015 Feb;59(2):284-92. doi: 10.1002/mnfr.201400518. Epub 2014 Dec 12. Mol Nutr Food Res. 2015. PMID: 25387687

9

Dietary extra virgin olive oil polyphenols supplementation modulates DSS-induced chronic colitis in mice.

Sánchez-Fidalgo S, Cárdeno A, Sánchez-Hidalgo M, Aparicio-Soto M, de la Lastra CA. Sánchez-Fidalgo S, et al. Among authors: de la lastra ca. J Nutr Biochem. 2013 Jul;24(7):1401-13. doi: 10.1016/j.jnutbio.2012.11.008. Epub 2013 Jan 18. J Nutr Biochem. 2013. PMID: 23337347

10

Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice.

Sánchez-Fidalgo S, Cárdeno A, Villegas I, Talero E, de la Lastra CA. Sánchez-Fidalgo S, et al. Among authors: de la lastra ca. Eur J Pharmacol. 2010 May 10;633(1-3):78-84. doi: 10.1016/j.ejphar.2010.01.025. Epub 2010 Feb 2. Eur J Pharmacol. 2010. PMID: 20132809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results